Skip to Content

T. Rowe Price Integrated US LCV Eq I TQVIX

Medalist Rating as of | See T. Rowe Price Investment Hub
  • NAV / 1-Day Return 17.40  /  −0.46 %
  • Total Assets 35.1 Mil
  • Adj. Expense Ratio
    0.530%
  • Expense Ratio 0.530%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 500,000
  • Status Open
  • TTM Yield 1.71%
  • Turnover 64%

USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 10:18 PM GMT+0

Morningstar’s Analysis TQVIX

Will TQVIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin T. Rowe Price Integrated US LCV Eq I's Morningstar Medalist Rating of Gold.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TQVIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 16.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

JPMorgan Chase & Co

3.11 1.1 Mil
Financial Services

Wells Fargo & Co

1.90 666,482
Financial Services

Exxon Mobil Corp

1.69 593,056
Energy

Citigroup Inc

1.60 559,548
Financial Services

Medtronic PLC

1.39 487,081
Healthcare

GE Aerospace

1.36 475,862
Industrials

Procter & Gamble Co

1.35 473,608
Consumer Defensive

Elevance Health Inc

1.33 465,649
Healthcare

The Cigna Group

1.30 454,714
Healthcare

iShares Russell 1000 Value ETF

1.27 445,984